Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19

Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19

Background: COVID-19 patients may experience “cytokine storm” when human immune system produces excessive cytokines/chemokines. However, it remains unclear whether early responses of inflammatory cytokines would lead to high or low titers of anti-SARS-CoV-2 antibodies. Methods: This retrospective st...

Full description

Bibliographic Details
Main Authors: De Clercq, E. (Author), Faria, N.R (Author), Jing, X. (Author), Lam, T.T.-Y (Author), Li, G. (Author), Song, D. (Author), Wang, Y. (Author), Xu, M. (Author), Yue, T. (Author), Zhang, M. (Author), Zhang, P. (Author), Zhong, Y. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
adult
aged
antibody titer
Article
clinical article
comorbidity
coronavirus disease 2019
correlational study
COVID-19
critically ill patient
cytokine
Cytokine dynamics
death
disease association
disease classification
disease severity
female
hospital admission
hospitalization
human
IgG
IgM
immunoglobulin G antibody
immunoglobulin M antibody
interleukin 10
interleukin 2 receptor
interleukin 6
interleukin 8
male
retrospective study
SARS-CoV-2
SARS-CoV-2 antibody
survival analysis
survival time
tumor necrosis factor
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items